Date published: 2026-6-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZBP-89 Activators

The chemical class referred to as ZBP-89 Activators encompasses a diverse group of compounds that, while not directly interacting with ZBP-89, can modulate cellular pathways and processes that ultimately influence the activity of this zinc finger protein. These compounds operate through distinct mechanisms, affecting various cellular signaling pathways and transcription factors, which in turn can alter the functional state of ZBP-89.

The primary mechanisms through which these chemicals exert their influence include modulation of gene expression, alteration of signaling pathways like NF-κB, PI3K/Akt, JNK, and MAPK/ERK, and effects on chromatin remodeling and histone modification. For instance, compounds like Retinoic Acid and EGCG indirectly affect ZBP-89 by modulating the JNK and NF-κB pathways, respectively, which are known to interact with transcription factors associated with ZBP-89. Similarly, Curcumin and Resveratrol impact the PI3K/Akt and sirtuin pathways, respectively, creating a cascade of cellular events that can influence the regulatory roles of ZBP-89 in gene expression and cell cycle processes. Furthermore, the use of histone deacetylase inhibitors like Sodium Butyrate exemplifies the indirect approach to influencing ZBP-89's activity by altering chromatin structure and gene expression patterns. Inhibitors of key kinases and enzymes, such as Forskolin, Lithium Chloride, and Rapamycin, demonstrate the broad spectrum of cellular processes that can be modulated to indirectly affect the activity of ZBP-89.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, SP600125 can modulate the AP-1 transcription factor, potentially influencing ZBP-89's activity in gene regulation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

As an mTOR inhibitor, Rapamycin affects cell growth and proliferation pathways, which can indirectly influence ZBP-89's activity in gene regulation and cell cycle processes.